Concept paper: Predictive biomarker-based assay development in the context of drug development and lifecycle

As part of its advocacy program in Europe, ACRO submits regulatory comments to European officials. This comment letter, submitted by ACRO to EMA in 2017 about Concept paper: Predictive biomarker-based assay development in the context of drug development and lifecycle can be found below.

Concept paper: Predictive biomarker-based assay development in the context of drug development and lifecycle

Scroll to Top